HEADER ISOMERASE/ISOMERASE INHIBITOR 26-MAR-12 4EC0 TITLE CRYSTAL STRUCTURE OF HH-PGDS WITH WATER DISPLACING INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: H-PGDS, GST CLASS-SIGMA, GLUTATHIONE S-TRANSFERASE, COMPND 5 GLUTATHIONE-DEPENDENT PGD SYNTHASE, GLUTATHIONE-REQUIRING COMPND 6 PROSTAGLANDIN D SYNTHASE, PROSTAGLANDIN-H2 D-ISOMERASE; COMPND 7 EC: 5.3.99.2, 2.5.1.18; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSTS, HPGDS, PGDS, PTGDS2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, SOLVENT REPLACEMENT, ISOMERASE-ISOMERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DAY,A.THORARENSEN,J.I.TRUJILLO REVDAT 4 28-FEB-24 4EC0 1 REMARK SEQADV LINK REVDAT 3 15-NOV-17 4EC0 1 REMARK REVDAT 2 02-JAN-13 4EC0 1 JRNL REVDAT 1 16-MAY-12 4EC0 0 JRNL AUTH J.I.TRUJILLO,J.R.KIEFER,W.HUANG,J.E.DAY,J.MOON,G.M.JEROME, JRNL AUTH 2 C.P.BONO,C.M.KORNMEIER,M.L.WILLIAMS,C.KUHN,G.R.RENNIE, JRNL AUTH 3 T.A.WYNN,C.P.CARRON,A.THORARENSEN JRNL TITL INVESTIGATION OF THE BINDING POCKET OF HUMAN HEMATOPOIETIC JRNL TITL 2 PROSTAGLANDIN (PG) D2 SYNTHASE (HH-PGDS): A TALE OF TWO JRNL TITL 3 WATERS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 3795 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22546671 JRNL DOI 10.1016/J.BMCL.2012.04.004 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 32124 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3302 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 761 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4EC0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-APR-12. REMARK 100 THE DEPOSITION ID IS D_1000071427. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32926 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.85300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 36 -18.35 -49.56 REMARK 500 SER A 44 5.61 -63.10 REMARK 500 GLN A 63 106.09 76.63 REMARK 500 GLN B1063 104.88 72.57 REMARK 500 GLU B1106 127.35 -12.77 REMARK 500 GLU B1113 0.71 -68.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 412 O REMARK 620 2 HOH A 423 O 83.5 REMARK 620 3 HOH A 459 O 90.7 88.2 REMARK 620 4 HOH B1372 O 91.9 173.4 87.1 REMARK 620 5 HOH B1384 O 167.9 85.9 94.9 99.1 REMARK 620 6 HOH B1437 O 89.2 92.4 179.4 92.3 85.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PQ A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH B 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4EE0 RELATED DB: PDB REMARK 900 RELATED ID: 4EDY RELATED DB: PDB REMARK 900 RELATED ID: 4EDZ RELATED DB: PDB DBREF 4EC0 A 1 199 UNP O60760 HPGDS_HUMAN 1 199 DBREF 4EC0 B 1001 1199 UNP O60760 HPGDS_HUMAN 1 199 SEQADV 4EC0 HIS A 0 UNP O60760 EXPRESSION TAG SEQADV 4EC0 HIS B 1000 UNP O60760 EXPRESSION TAG SEQRES 1 A 200 HIS MET PRO ASN TYR LYS LEU THR TYR PHE ASN MET ARG SEQRES 2 A 200 GLY ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA TYR LEU SEQRES 3 A 200 ASP ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN ALA ASP SEQRES 4 A 200 TRP PRO GLU ILE LYS SER THR LEU PRO PHE GLY LYS ILE SEQRES 5 A 200 PRO ILE LEU GLU VAL ASP GLY LEU THR LEU HIS GLN SER SEQRES 6 A 200 LEU ALA ILE ALA ARG TYR LEU THR LYS ASN THR ASP LEU SEQRES 7 A 200 ALA GLY ASN THR GLU MET GLU GLN CYS HIS VAL ASP ALA SEQRES 8 A 200 ILE VAL ASP THR LEU ASP ASP PHE MET SER CYS PHE PRO SEQRES 9 A 200 TRP ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN MET PHE SEQRES 10 A 200 ASN GLU LEU LEU THR TYR ASN ALA PRO HIS LEU MET GLN SEQRES 11 A 200 ASP LEU ASP THR TYR LEU GLY GLY ARG GLU TRP LEU ILE SEQRES 12 A 200 GLY ASN SER VAL THR TRP ALA ASP PHE TYR TRP GLU ILE SEQRES 13 A 200 CYS SER THR THR LEU LEU VAL PHE LYS PRO ASP LEU LEU SEQRES 14 A 200 ASP ASN HIS PRO ARG LEU VAL THR LEU ARG LYS LYS VAL SEQRES 15 A 200 GLN ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS ARG ARG SEQRES 16 A 200 PRO GLN THR LYS LEU SEQRES 1 B 200 HIS MET PRO ASN TYR LYS LEU THR TYR PHE ASN MET ARG SEQRES 2 B 200 GLY ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA TYR LEU SEQRES 3 B 200 ASP ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN ALA ASP SEQRES 4 B 200 TRP PRO GLU ILE LYS SER THR LEU PRO PHE GLY LYS ILE SEQRES 5 B 200 PRO ILE LEU GLU VAL ASP GLY LEU THR LEU HIS GLN SER SEQRES 6 B 200 LEU ALA ILE ALA ARG TYR LEU THR LYS ASN THR ASP LEU SEQRES 7 B 200 ALA GLY ASN THR GLU MET GLU GLN CYS HIS VAL ASP ALA SEQRES 8 B 200 ILE VAL ASP THR LEU ASP ASP PHE MET SER CYS PHE PRO SEQRES 9 B 200 TRP ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN MET PHE SEQRES 10 B 200 ASN GLU LEU LEU THR TYR ASN ALA PRO HIS LEU MET GLN SEQRES 11 B 200 ASP LEU ASP THR TYR LEU GLY GLY ARG GLU TRP LEU ILE SEQRES 12 B 200 GLY ASN SER VAL THR TRP ALA ASP PHE TYR TRP GLU ILE SEQRES 13 B 200 CYS SER THR THR LEU LEU VAL PHE LYS PRO ASP LEU LEU SEQRES 14 B 200 ASP ASN HIS PRO ARG LEU VAL THR LEU ARG LYS LYS VAL SEQRES 15 B 200 GLN ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS ARG ARG SEQRES 16 B 200 PRO GLN THR LYS LEU HET GSH A 201 20 HET MG A 202 1 HET 7PQ A 203 29 HET GSH B1201 20 HETNAM GSH GLUTATHIONE HETNAM MG MAGNESIUM ION HETNAM 7PQ 4-[2-(AMINOMETHYL)NAPHTHALEN-1-YL]-N-[2-(MORPHOLIN-4- HETNAM 2 7PQ YL)ETHYL]BENZAMIDE FORMUL 3 GSH 2(C10 H17 N3 O6 S) FORMUL 4 MG MG 2+ FORMUL 5 7PQ C24 H27 N3 O2 FORMUL 7 HOH *761(H2 O) HELIX 1 1 ALA A 15 ASP A 26 1 12 HELIX 2 2 ASP A 38 LYS A 43 1 6 HELIX 3 3 SER A 44 LEU A 46 5 3 HELIX 4 4 GLN A 63 LYS A 73 1 11 HELIX 5 5 THR A 81 CYS A 101 1 21 HELIX 6 6 LYS A 108 TYR A 122 1 15 HELIX 7 7 TYR A 122 GLY A 136 1 15 HELIX 8 8 THR A 147 LYS A 164 1 18 HELIX 9 9 HIS A 171 ALA A 183 1 13 HELIX 10 10 ILE A 184 ARG A 194 1 11 HELIX 11 11 ALA B 1015 LEU B 1025 1 11 HELIX 12 12 GLU B 1035 ALA B 1037 5 3 HELIX 13 13 ASP B 1038 THR B 1045 1 8 HELIX 14 14 GLN B 1063 LYS B 1073 1 11 HELIX 15 15 THR B 1081 SER B 1100 1 20 HELIX 16 16 LYS B 1108 ASN B 1123 1 16 HELIX 17 17 ASN B 1123 GLY B 1136 1 14 HELIX 18 18 THR B 1147 LYS B 1164 1 18 HELIX 19 19 HIS B 1171 ILE B 1184 1 14 HELIX 20 20 ILE B 1184 ARG B 1194 1 11 SHEET 1 A 4 GLU A 30 ARG A 33 0 SHEET 2 A 4 TYR A 4 TYR A 8 1 N TYR A 4 O GLU A 30 SHEET 3 A 4 ILE A 53 VAL A 56 -1 O GLU A 55 N LYS A 5 SHEET 4 A 4 LEU A 59 HIS A 62 -1 O LEU A 59 N VAL A 56 SHEET 1 B 4 GLU B1030 ILE B1034 0 SHEET 2 B 4 TYR B1004 PHE B1009 1 N LEU B1006 O GLU B1030 SHEET 3 B 4 ILE B1053 VAL B1056 -1 O GLU B1055 N LYS B1005 SHEET 4 B 4 LEU B1059 HIS B1062 -1 O LEU B1059 N VAL B1056 LINK MG MG A 202 O HOH A 412 1555 1555 2.30 LINK MG MG A 202 O HOH A 423 1555 1555 2.36 LINK MG MG A 202 O HOH A 459 1555 1555 2.28 LINK MG MG A 202 O HOH B1372 1555 1555 2.34 LINK MG MG A 202 O HOH B1384 1555 1555 2.39 LINK MG MG A 202 O HOH B1437 1555 1555 2.26 CISPEP 1 ILE A 51 PRO A 52 0 0.80 CISPEP 2 ILE B 1051 PRO B 1052 0 0.76 SITE 1 AC1 17 TYR A 8 ARG A 14 TRP A 39 LYS A 43 SITE 2 AC1 17 LYS A 50 ILE A 51 PRO A 52 GLN A 63 SITE 3 AC1 17 SER A 64 7PQ A 203 HOH A 301 HOH A 402 SITE 4 AC1 17 HOH A 464 HOH A 472 HOH A 652 HOH A 684 SITE 5 AC1 17 ASP B1097 SITE 1 AC2 6 HOH A 412 HOH A 423 HOH A 459 HOH B1372 SITE 2 AC2 6 HOH B1384 HOH B1437 SITE 1 AC3 11 TYR A 8 GLY A 13 ARG A 14 ASP A 96 SITE 2 AC3 11 MET A 99 TRP A 104 TYR A 152 THR A 159 SITE 3 AC3 11 LEU A 199 GSH A 201 HOH A 461 SITE 1 AC4 15 ASP A 97 TYR B1008 ARG B1014 TRP B1039 SITE 2 AC4 15 LYS B1043 LYS B1050 ILE B1051 GLN B1063 SITE 3 AC4 15 SER B1064 HOH B1309 HOH B1353 HOH B1404 SITE 4 AC4 15 HOH B1430 HOH B1438 HOH B1649 CRYST1 48.740 77.706 52.449 90.00 91.56 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020517 0.000000 0.000559 0.00000 SCALE2 0.000000 0.012869 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019073 0.00000